Trials / Completed
CompletedNCT04070846
Mass Balance Study of [14C]LC350189 in Healthy Volunteers
A Phase 1, Open-Label, Single-Dose, Mass Balance Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]-LC350189 in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- LG Chem · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This is a Phase 1, open-label, single-dose, mass balance study designed to evaluate the absorption, metabolism, and excretion of \[14C\] radiolabeled LC350189 after oral administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [14C] LC350189 | Carbon-14 labelded LC350189 |
Timeline
- Start date
- 2020-02-26
- Primary completion
- 2020-03-07
- Completion
- 2020-03-07
- First posted
- 2019-08-28
- Last updated
- 2020-06-26
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04070846. Inclusion in this directory is not an endorsement.